Michael A. Panzara, Franchise Lead, Neurology at Wave Life Sciences Ltd. (WVE), sold 511 shares at $52.10 ($27K) on 2018-02-16, disclosed to the SEC on 2018-02-21.
Scheduled sale ($27k) by Franchise Lead, Neurology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| WVE | SELL | 2021-02-18 | $31K | — | Filing → |
| WVE | SELL | 2020-02-20 | $23K | — | Filing → |
| WVE | SELL | 2019-07-09 | $153K | — | Filing → |